Treace Medical Concepts reports declining revenue due to increased competition.
ByAinvest
Monday, Jun 9, 2025 5:47 am ET1min read
TMCI--
The lawsuit alleges that during the class period, TMCI made false and/or misleading statements and failed to disclose significant information. These include:
1. Increased competition impacting the demand and utilization of their primary product, the Lapiplasty 3D Bunion Correction System.
2. Revenue decline as a result of the aforementioned competition, leading to the acceleration of plans for an alternative product.
3. Materially misleading statements about the company's business, operations, and prospects.
Investors who suffered losses in excess of $100,000 are encouraged to contact the Rosen Law Firm for more information. The lead plaintiff deadline is June 10, 2025. It is important to note that being a lead plaintiff is not a requirement for recovery. Investors can remain absent class members and still participate in the class action [1].
The Rosen Law Firm has a proven track record in securities class actions, having recovered hundreds of millions of dollars for investors. The firm was ranked No. 1 by ISS Securities Class Action Services for the number of securities class action settlements in 2017 and has been ranked in the top 4 each year since 2013 [1].
Investors are encouraged to seek qualified counsel to protect their rights. The Rosen Law Firm can be contacted via their website at [https://rosenlegal.com](https://rosenlegal.com) or by phone at 866-767-3653.
References:
[1] https://www.globenewswire.com/news-release/2025/06/08/3095582/673/en/TMCI-FINAL-DEADLINE-ROSEN-NATIONAL-TRIAL-COUNSEL-Encourages-Treace-Medical-Concepts-Inc-Investors-with-Losses-in-Excess-of-100K-to-Secure-Counsel-Before-Important-June-10-Deadline-.html
• Treace Medical Concepts reports decline in revenue • Primary product Lapiplasty faces increased competition • Demand and utilization of Lapiplasty impacted • Company accelerates plans for alternative product • Securities class action lawsuit filed • Shareholders encouraged to contact Gross Law Firm • Lead plaintiff appointment not required for recovery • Treace Medical Concepts, Inc. (NASDAQ: TMCI) • Class period: May 8, 2023 to May 7, 2024
Treace Medical Concepts, Inc. (TMCI), a medical device company listed on NASDAQ, is facing a securities fraud lawsuit. The Rosen Law Firm, a global investor rights law firm, has announced that investors who purchased TMCI securities between May 8, 2023, and May 7, 2024, may be eligible to join a class action lawsuit.The lawsuit alleges that during the class period, TMCI made false and/or misleading statements and failed to disclose significant information. These include:
1. Increased competition impacting the demand and utilization of their primary product, the Lapiplasty 3D Bunion Correction System.
2. Revenue decline as a result of the aforementioned competition, leading to the acceleration of plans for an alternative product.
3. Materially misleading statements about the company's business, operations, and prospects.
Investors who suffered losses in excess of $100,000 are encouraged to contact the Rosen Law Firm for more information. The lead plaintiff deadline is June 10, 2025. It is important to note that being a lead plaintiff is not a requirement for recovery. Investors can remain absent class members and still participate in the class action [1].
The Rosen Law Firm has a proven track record in securities class actions, having recovered hundreds of millions of dollars for investors. The firm was ranked No. 1 by ISS Securities Class Action Services for the number of securities class action settlements in 2017 and has been ranked in the top 4 each year since 2013 [1].
Investors are encouraged to seek qualified counsel to protect their rights. The Rosen Law Firm can be contacted via their website at [https://rosenlegal.com](https://rosenlegal.com) or by phone at 866-767-3653.
References:
[1] https://www.globenewswire.com/news-release/2025/06/08/3095582/673/en/TMCI-FINAL-DEADLINE-ROSEN-NATIONAL-TRIAL-COUNSEL-Encourages-Treace-Medical-Concepts-Inc-Investors-with-Losses-in-Excess-of-100K-to-Secure-Counsel-Before-Important-June-10-Deadline-.html
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet